Protocolised Early De-Resuscitation in Septic Shock (REDUCE)
REDUCE
1 other identifier
interventional
170
1 country
4
Brief Summary
Background: Recent studies have questioned the safety of current fluid resuscitation strategies in patients with septic shock as prospective and observational data suggesting that the resulting fluid overload is associated with mortality. Two strategies have evolved to prevent or minimize fluid overload: restrictive fluid administration or active removal of accumulated fluid. While several small trials show benefits with a restrictive fluid administration regimen, active protocolized de-resuscitation was scarcely evaluated. The combination of both strategies yet warrants systematic evaluation. Aim: This study aims to assess the efficacy and feasibility of an early active de-resuscitation protocol in patients with septic shock. We hypothesize that the application of a structured early de-resuscitation protocol versus standard of care will lead to less fluid overload at day three after ICU admission. Study Intervention: Patients admitted to the ICU with confirmed or suspected septic shock (Sepsis-3 definition) will be randomized (1:1) to either the intervention or standard of care. In the intervention arm, patients are managed according to the REDUCE fluid management protocol during resuscitation and de-resuscitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2021
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2021
CompletedFirst Posted
Study publicly available on registry
June 18, 2021
CompletedStudy Start
First participant enrolled
July 19, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 7, 2025
CompletedMay 5, 2026
April 1, 2026
3.6 years
May 14, 2021
April 28, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of patient with a negative fluid balance on day 3
Proportion of patients with a negative cumulative fluid balance on day 3
Up to day 3 after ICU admission
Secondary Outcomes (8)
Number of patients with fluid overload at day 3 and ICU discharge
From hospital admission to the end of ICU stay, on average after 7 days
Feasibility of the REDUCE fluid protocol
From randomisation until the end of ICU stay, on average after 7 days
Incidence of ischemic events and severe AKI
Ischemic events and AKI: From randomisation until the end of ICU stay (on average after 7 days), and at day 30; electrolyte and acid-base/medication associated safety endpoints: during ICU stay (on average 7 days)
Ventilator-free days at day 30
Up to 30 days after randomisation
Vasopressor-free days at day 30
Up to 30 days after randomisation
- +3 more secondary outcomes
Other Outcomes (1)
Daily cumulative fluid balance up to day 7
Throughout the ICU stay, on average 7 days
Study Arms (2)
Intervention: REDUCE Protocol
EXPERIMENTALFluid resuscitation and de-resuscitation is based on the REDUCE fluid management protocol.
Standard of Care
ACTIVE COMPARATORFluid resuscitation and de-resuscitation according to the standard of care
Interventions
Fluid management according to the protocol will be guided by pre-defined clinical signs for impaired perfusion and fluid overload.
Fluid resuscitation and de-resuscitation will be managed according to the standard of care
Eligibility Criteria
You may qualify if:
- Patients admitted to ICU with the diagnosis of septic shock as defined according to the Sepsis-3 criteria (suspected or confirmed infection AND vasopressor/inotrope ongoing to maintain MAP ≥ 65 mmHg AND Lactate ≥ 2 mmol/l in the last 6 hours
You may not qualify if:
- Age \<18 years
- Septic shock for more than 12 hours at the time of screening
- Acute burn injury \>/= 10% of the body surface area
- Known pregnancy or lactating women
- Consent not obtainable due to national legislation
- Patients on chronic dialysis
- Patients that are known to be allergic to furosemide or metolazone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
University Hospital Basel
Basel, 4031, Switzerland
University Hospital Bern, Inselspital
Bern, 3010, Switzerland
Cantonal Hospital St. Gallen
Sankt Gallen, 9000, Switzerland
Kantonsspital Winterthur
Winterthur, 8400, Switzerland
Related Publications (1)
Messmer A, Pietsch U, Siegemund M, Buehler P, Waskowski J, Muller M, Uehlinger DE, Hollinger A, Filipovic M, Berger D, Schefold JC, Pfortmueller CA. Protocolised early de-resuscitation in septic shock (REDUCE): protocol for a randomised controlled multicentre feasibility trial. BMJ Open. 2023 Sep 21;13(9):e074847. doi: 10.1136/bmjopen-2023-074847.
PMID: 37734896BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Anna S Messmer, MD
Department of Intensive Care, Inselspital, Bern University Hospital, Bern, Switzerland
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors will be blinded to the treatment allocation.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 14, 2021
First Posted
June 18, 2021
Study Start
July 19, 2021
Primary Completion
February 10, 2025
Study Completion
May 7, 2025
Last Updated
May 5, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share